Antiproliferation and colony-forming inhibition activities of recombinant feline interferon (rFeIFN) on various cells in vitro
- PMID: 7704845
- PMCID: PMC1263736
Antiproliferation and colony-forming inhibition activities of recombinant feline interferon (rFeIFN) on various cells in vitro
Abstract
The antiproliferative and colony inhibiting activities of recombinant feline interferon (rFeIFN Type I) against various cells in vitro were examined. Feline and canine cells were both sensitive to rFeIFN. To inhibit the growth of feline cells by 50% approximately 5 x 10(2) to 1 x 10(3) U/mL rFeIFN was required and maximum activity was achieved at a concentration of 1 x 10(5) U/mL. Approximately 5 x 10(3) to 5 x 10(4) U/mL rFeIFN was necessary to inhibit the growth of canine cells by 50%. The antiproliferative and colony inhibiting activities of rFeIFN on canine cells appeared to be cell-specific and dose-dependent. However, human, monkey and hamster cells were resistant to rFeIFN. We suggest that rFeIFN might be useful for treatment of feline and some canine neoplastic conditions.
Similar articles
-
Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours.Vet Comp Oncol. 2009 Dec;7(4):222-9. doi: 10.1111/j.1476-5829.2009.00192.x. Vet Comp Oncol. 2009. PMID: 19891692
-
The biological effects of five feline IFN-alpha subtypes.Vet Immunol Immunopathol. 2004 Jun;99(3-4):153-67. doi: 10.1016/j.vetimm.2004.01.012. Vet Immunol Immunopathol. 2004. PMID: 15135982
-
Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells.Am J Vet Res. 2006 Jun;67(6):1025-32. doi: 10.2460/ajvr.67.6.1025. Am J Vet Res. 2006. PMID: 16740097 Clinical Trial.
-
In vitro growth inhibition activities of recombinant feline interferon on all lines derived from canine tumours.Res Vet Sci. 1995 Nov;59(3):275-7. doi: 10.1016/0034-5288(95)90017-9. Res Vet Sci. 1995. PMID: 8588106
-
Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega.Cytokine. 2014 Mar;66(1):54-9. doi: 10.1016/j.cyto.2013.12.001. Epub 2014 Jan 14. Cytokine. 2014. PMID: 24548425 Clinical Trial.
Cited by
-
In vitro Effect of Recombinant Feline Interferon-Ω (rFeIFN-Ω) on the Primary CanineTransmissible Venereal Tumor Culture.Front Vet Sci. 2019 Apr 9;6:104. doi: 10.3389/fvets.2019.00104. eCollection 2019. Front Vet Sci. 2019. PMID: 31024941 Free PMC article.
-
In vitro antiproliferation activity of Typhonium flagelliforme leaves ethanol extract and its combination with canine interferons on several tumor-derived cell lines.Vet World. 2020 May;13(5):931-939. doi: 10.14202/vetworld.2020.931-939. Epub 2020 May 19. Vet World. 2020. PMID: 32636590 Free PMC article.
-
Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega.J Vet Intern Med. 2007 Nov-Dec;21(6):1340-6. doi: 10.1892/06-201.1. J Vet Intern Med. 2007. PMID: 18196745 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources